Inventor
Thilo J. Heckrodt
Inventor
San Francisco, CA, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07BGeneral methods of organic chemistry4%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C12YEnzymes2%
Y02ATechnologies for adaptation to climate change2%
C07KPeptides1%
PatentTitleYear
10,947,216Amide compounds and method for making and using202110,941,140IRAK inhibitors and method for making and using202110,792,282Protein kinase C inhibitors and uses thereof202010,479,783Compositions and methods for inhibition of the JAK pathway201910,414,753Amide compounds and method for making and using201910,370,367IRAK inhibitors and method for making and using2019RE047396Compositions and methods for inhibition of the JAK pathway201910,208,075Pyrazole compounds and method for making and using the compounds201910,208,074Pyrazole compounds and method for making and using the compounds201910,166,216Substituted triazoles useful as Axl inhibitors201910,005,777Protein kinase C inhibitors and uses thereof20189,982,000Pyrazole compounds and method for making and using the compounds20189,920,041'Compositions and methods for inhibition of the JAK pathway'20189,913,843'Protein kinase C inhibitors and uses thereof'20189,682,976'Protein kinase C inhibitors and uses thereof'20179,650,391'N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors'20179,611,260'Compositions and methods for inhibition of the JAK pathway'20179,566,278'Protein kinase C inhibitors and uses thereof'20179,353,126'Substituted triazoles useful as Axl inhibitors'20169,321,763'Protein kinase C inhibitors and uses thereof'20169,206,161'Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20159,173,882'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20159,169,249'Protein kinase C inhibitors and uses thereof'20159,156,820'Polycyclic heteroaryl substituted triazoles useful as axl inhibitors'20159,084,795'Compositions and methods for inhibition of the JAK pathway'20159,079,898'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20159,067,925'Compositions and methods for inhibition of the JAK pathway'20159,062,068'Protein kinase C inhibitors and uses thereof'20159,029,501'Method for making macrocycles'20158,933,080'Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors'20158,906,922'Substituted triazoles useful as AXl inhibitors'20148,809,347'Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors'20148,809,364'Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors'20148,796,259'N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors'20148,741,898'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20148,658,669'Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20148,618,331'Polycyclic heteroaryl substituted triazoles useful as axl inhibitors'20138,492,373'Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20138,431,594'Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors'20138,349,838'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20138,343,954'Compositions and methods for inhibition of the JAK pathway'20138,324,200'Compositions and methods for inhibition of the JAK pathway'20128,168,636'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20127,935,693'Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20117,872,000'Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20117,709,482'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2021Patents assigned to RIGEL PHARMACEUTICALS INC (46)· patent assignee history
2010–2021Based in San Francisco, CA, US· patent location history
2012–2017Patents assigned to HECKRODT THILO J (13)· patent assignee history
2012–2017Patents assigned to SINGH RAJINDER (13)· patent assignee history
2012–2017Patents assigned to HOLLAND SACHA (10)· patent assignee history
2012–2017Patents assigned to GOFF DANE (9)· patent assignee history
2014Based in South San Francisco, CA, US· patent location history
2019Based in San Bernardino, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIGEL PHARMACEUTICALS INC | 46 | 2010–2021 |
| HECKRODT THILO Jself | 13 | 2012–2017 |
| SINGH RAJINDER | 13 | 2012–2017 |
| HOLLAND SACHA | 10 | 2012–2017 |
| GOFF DANE | 9 | 2012–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 44 | 2010–2021 |
| San Bernardino, California, US | 1 | 2019 |
| South San Francisco, California, US | 1 | 2014 |